Who gets the credit for GLP-1?

And is "rolling the dice" an uncouth metaphor for this ALS treatment?

September 29, 2023 Check out STAT+

Sponsored By

When is negative data positive enough? Who gets credit for scientific breakthroughs? And wasn't biotech supposed to bounce back? We cover all that and more this week on "The Readout LOUD," STAT's biotech podcast. Our colleague Elaine Chen joins us to explain the story of Svetlana Mojsov, a chemist who played a vital role in the discovery of GLP-1 who has spent decades fighting for proper recognition. We also discuss the latest news in the life sciences, including the FDA hearing on a BrainStorm Cell Therapeutics' polarizing ALS treatment, the end of the road for a once-vaunted drug developer, and the sorry state of biotech stocks. Listen Now Subscribe to the podcast to never miss an episode iTunes Google Spotify SoundCloud Podcast Addict TuneIn Visit the archive to see past episodes

---

---

Enjoying The Readout LOUD? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser